B of A Securities Downgrades FMC to Underperform, Announces $128 Price Target
B of A Securities analyst Steve Byrne downgrades FMC (NYSE:FMC) from Buy to Underperform and announces $128 price target.
Citigroup Maintains Buy on FMC, Raises Price Target to $152
Citigroup analyst PJ Juvekar maintains FMC (NYSE:FMC) with a Buy and raises the price target from $137 to $152.
Morgan Stanley Maintains Equal-Weight on FMC, Raises Price Target to $125
Morgan Stanley analyst Vincent Andrews maintains FMC (NYSE:FMC) with a Equal-Weight and raises the price target from $115 to $125.
Wells Fargo Maintains Overweight on FMC, Raises Price Target to $130
Wells Fargo analyst Michael Sison maintains FMC (NYSE:FMC) with a Overweight and raises the price target from $123 to $130.
Mid-Morning Market Update: Markets Open Higher; Nasdaq Gains Over 1%
US stocks opened on strong note on Wednesday, while the Nasdaq Composite surging more than 1% this morning.
Recap: FMC Q4 Earnings
FMC (NYSE:FMC) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
FMC beat estimated earnings by 7.46%, reporting an EPS of $2.16 versus an estimate of $2.01.
FMC Q4 Adj. EPS $2.16 Beats $2.01 Estimate, Sales $1.41B Beat $1.38B Estimate
FMC (NYSE:FMC) reported quarterly earnings of $2.16 per share which beat the analyst consensus estimate of $2.01 by 7.46 percent. This is a 52.11 percent increase over earnings of $1.42 per share from the same period
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell
• Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Expert Ratings For FMC
FMC (NYSE:FMC) has observed the following analyst ratings within the last quarter:
Redburn Partners Initiates Coverage On FMC with Buy Rating
Redburn Partners analyst Tony Jones initiates coverage on FMC (NYSE:FMC) with a Buy rating.